We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$21.8B
AUM Growth
+$3.36B
(+18%)
Cap. Flow
+$2.78B
Cap. Flow
% of AUM
12.74%
Top 10 Holdings %
Top 10 Hldgs %
12.04%
Holding
3,109
New
1,280
Increased
559
Reduced
519
Closed
699
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARA
Paramount Global Class B
PARA
|
+$363M |
| 2 |
Tencent Music
TME
|
+$184M |
| 3 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$182M |
| 4 |
Baidu
BIDU
|
+$146M |
| 5 |
Gaotu Techedu
GOTU
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$204M |
| 2 |
Carnival Corporation Ltd
CCL
|
+$189M |
| 3 |
Zoetis
ZTS
|
+$182M |
| 4 |
Guardant Health
GH
|
+$136M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.03% |
| 2 | Consumer Discretionary | 13.15% |
| 3 | Technology | 10.68% |
| 4 | Financials | 9.81% |
| 5 | Communication Services | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Sysco
SYY
$39.7B
| $36.6M | 0.17% |
465,218
+357,428
| +332% | +$27.7M |
|
127
Autohome
ATHM
$2.43B
| $36.6M | 0.17% |
392,495
+370,274
| +1,666% | +$41.1M |
|
128
Enbridge
ENB
$124B
| $36.5M | 0.17% |
1,003,524
-389,448
| -28% | -$13.7M |
|
129
Magna International
MGA
$17.9B
| $36M | 0.17% |
409,184
+350,210
| +594% | +$28.4M |
|
130
Salesforce
CRM
$134B
| $35.3M | 0.16% |
166,432
+133,012
| +398% | +$29.6M |
|
131
Under Armour Class C
UA
$2.92B
| $34.9M | 0.16% |
1,892,504
+881,879
| +87% | +$15.5M |
|
132
CarMax
KMX
$8.27B
| $34M | 0.16% |
256,629
+199,633
| +350% | +$24.3M |
|
133
Adobe
ADBE
$89.5B
| $33.6M | 0.15% |
70,708
+63,165
| +837% | +$29.5M |
|
134
Prudential Financial
PRU
$41.7B
| $33.6M | 0.15% |
368,668
-169,384
| -31% | -$14.5M |
|
135
Las Vegas Sands
LVS
$30.5B
| $33M | 0.15% |
542,561
+262,694
| +94% | +$15.4M |
|
136
Scotiabank
BNS
$106B
| $32.9M | 0.15% |
526,571
-279,026
| -35% | -$16.2M |
|
137
Ulta Beauty
ULTA
$20.4B
| $32.2M | 0.15% |
104,136
+101,260
| +3,521% | +$31.5M |
|
|
138
Alphabet (Google) Class C
GOOG
$3.9T
| $32M | 0.15% |
308,960
-536,160
| -63% | -$53.2M |
|
139
Williams-Sonoma
WSM
$26.7B
| $31.8M | 0.15% |
355,436
+160,490
| +82% | +$10.8M |
|
140
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $31.8M | 0.15% |
292,141
+271,074
| +1,287% | +$30.3M |
|
141
Constellation Brands
STZ
$22.2B
| $31.3M | 0.14% |
137,070
+18,177
| +15% | +$4.1M |
|
142
GrowGeneration
GRWG
$82.9M
| $31M | 0.14% |
623,661
+523,467
| +522% | +$26.1M |
|
143
Texas Capital Bancshares
TCBI
$4.31B
| $31M | 0.14% |
+436,538
| New | +$32.1M |
|
144
Snap
SNAP
$7.32B
| $30.9M | 0.14% |
591,183
-291,510
| -33% | -$16.8M |
|
145
CVS Health
CVS
$137B
| $30.9M | 0.14% |
410,486
+399,334
| +3,581% | +$29.1M |
|
146
Danaher
DHR
$135B
| $30.8M | 0.14% |
154,140
-283,815
| -65% | -$57.6M |
|
147
GeneDx Holdings
WGS
$1.75B
| $30.4M | 0.14% |
+61,773
| New | +$32.1M |
|
148
Stellantis
STLA
$16.5B
| $30.3M | 0.14% |
1,710,447
-5,090,687
| -75% | -$85.6M |
|
149
Brown-Forman Class B
BF.B
$12B
| $30.2M | 0.14% |
437,220
+28,800
| +7% | +$2.11M |
|
150
Pfizer
PFE
$140B
| $30.1M | 0.14% |
+830,211
| New | +$29.5M |
|
Similar funds
Marshall Wace's Q1 2021 Portfolio in Review
As of Q1 2021, Marshall Wace held 3,109 positions worth $21.8B, up 18% from $18.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Marshall Wace deployed $2.78B of net new capital in Q1 2021, opening 1,280 new positions and adding to 559 existing holdings. Its largest new stake was Paramount Global Class B: 5,936,494 shares worth $268M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Technology.
On the sell side, the largest reduction was Thermo Fisher Scientific, an estimated $204M trimmed.
- Marshall Wace's largest Q1 2021 buy was Paramount Global Class B: 5,936,494 shares worth $268M.
- Marshall Wace added most to Farfetch Limited Class A Ordinary Shares in Q1 2021, an estimated $182M increase.
- Marshall Wace's biggest Q1 2021 reduction was Thermo Fisher Scientific, cutting an estimated $204M.
- Marshall Wace fully exited Vanguard Intermediate-Term Corporate Bond ETF in Q1 2021, selling an estimated $76.2M.
- Marshall Wace's ten largest holdings make up 12% of its $21.8B portfolio in Q1 2021.
- Marshall Wace opened 1,280 new positions and closed 699 in Q1 2021.
- Marshall Wace's portfolio value rose 18% quarter-over-quarter to $21.8B.
Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.